Artisan Partners Limited Partnership Abb Vie Inc. Transaction History

Artisan Partners Limited Partnership

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $39.1 Million - $44.4 Million	-367,799 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $8.57 Million - $9.55 Million	-81,498 Reduced 18.14%	367,799 $41.4 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $4.14 Million - $4.56 Million	-40,507 Reduced 8.27%	449,297 $48.6 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $296,847 - $400,774	-3,688 Reduced 0.75%	489,804 $52.5 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $6.74 Million - $7.92 Million	78,500 Added 18.92%	493,492 $43.2 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $30.4 Million - $40.7 Million	414,992 New	414,992 $40.7 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.